BIOSECURE Act heads for possible vote in House of Representatives next week

After running up against a roadblock earlier this summer, the controversial BIOSECURE Act could gain new momentum next week.

The U.S. House of Representatives is slated to consider the legislation during the week of Sept. 9, according to a website maintained by the congressional chamber. The bill was introduced in January and seeks to halt federal contracts with certain Chinese biotech equipment and service providers over national security concerns.